Risk Factors for the Development Metastases in Prostate Cancer Daniel P. Petrylak, MD, Columbia-Presbyterian Medical Center
On-Demand Multimedia Presentation
New Tools for the Urologist in the Management of Patients with Bone Metastases Bob Djavan, MD, Department of Urology, University of Vienna, Vienna, Austria and NYU, New York
On-Demand Multimedia Presentation
Bisphosphonates Can Prevent Skeletal Complications From Prostate and Renal Cell Carcinoma Fred Saad, MD,FRCS Professor of Surgery/Urology at the University of Montreal
On-Demand Multimedia Presentation
Skeletal Complications of GU Malignancies - Optimizing Treatment with Bisphosphonates Kurt Miller, MD, Professor and Chairman of Urology, Benjamin Franklin Medical Center, Berlin, Germany
On-Demand Multimedia Presentation
The Role Of Bisphosphonates In Metastatic Prostate Cancer (Co-Chair) Fred Saad MD FRCS Director of Urologic Oncology Professor of Surgery/Urology U of M Chair in Prostate Cancer University of Montreal PDF Slide Presentation On-Demand Multimedia Presentation
The Increasing Responsibility Of The Urologist In Maintaining Bone Health In Prostate Cancer Patients Kurt Miller, MD, Professor and Chairman of Urology at the Benjamin Franklin Medical Center, Charité, Berlin PDF Slide Presentation On-Demand Multimedia Presentation
The Role Of Bisphosphonates In The High Risk Patient Prof. Dr. Med. Dr. H.C.. Manfred Wirth, Chairman, Department of Urology, Medical School of Carl Gustav Carus, Technical University of Dresden, Germany PDF Slide Presentation On-Demand Multimedia Presentation
Reader Comments
Please log-in or register in order to submit comments.
Prostate Cancer 
